We have located links that may give you full text access.
Case Reports
Clinical Trial
Journal Article
The effect of indomethacin on para-articular ectopic ossification following total hip arthroplasty.
Three patients exhibiting Grade III para-articular ectopic ossification following bilateral hip arthroplasty were successfully treated by excision of the bone and small-dose, short-term indomethacin therapy. Based on these results, a preliminary study was performed to determine the effect of indomethacin used prophylactically in patients who were predisposed to ectopic ossification and were undergoing total hip arthroplasty. Of a retrospective control group of 24 hips with extensive bilateral osteoarthritis, 63% were found to develop ectopic ossification following arthroplasty compared to 17% of a similar group treated with indomethacin (p less than 0.001). The ectopic ossification in the indomethacin-treated group possibly was of lesser severity (Grade I) than that encountered in the control group.
Full text links
Related Resources
Trending Papers
Executive Summary: State-of-the-Art Review: Unintended Consequences: Risk of Opportunistic Infections Associated with Long-term Glucocorticoid Therapies in Adults.Clinical Infectious Diseases 2024 April 11
Clinical practice guidelines on the management of status epilepticus in adults: A systematic review.Epilepsia 2024 April 13
Autoimmune Hemolytic Anemias: Classifications, Pathophysiology, Diagnoses and Management.International Journal of Molecular Sciences 2024 April 13
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app